BioCentury
ARTICLE | Clinical News

Ditropan XL oxybutynin chloride: Marketed

July 9, 2001 7:00 AM UTC

Results from a U.S. post-marketing study of Ditropan XL in 14 patients with spinal cord injury and detrusor hyperreflexia (overactive bladder) showed that patients given 30 mg Ditropan XL daily had an...